New patent expiration for Gilead Sciences drug BIKTARVY

Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen…

The post New patent expiration for Gilead Sciences drug BIKTARVY appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog